taurodehydrocholate has been researched along with phosphatidylcholines in 2 studies
| Studies (taurodehydrocholate) | Trials (taurodehydrocholate) | Recent Studies (post-2010) (taurodehydrocholate) | Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) |
|---|---|---|---|---|---|
| 22 | 0 | 0 | 32,204 | 443 | 5,593 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coleman, R; Kan, KS; Parslow, RA; Rahman, K | 1 |
| Gros, P; Ruetz, S | 1 |
2 other study(ies) available for taurodehydrocholate and phosphatidylcholines
| Article | Year |
|---|---|
Retrograde intrabiliary injection of amphipathic materials causes phospholipid secretion into bile. Taurocholate causes phosphatidylcholine secretion, 3-[(3-cholamidopropyl)dimethylammonio]-propane-1-sulphonate (CHAPS) causes mixed phospholipid secretion.
Topics: Animals; Bile; Bile Acids and Salts; Cholic Acids; Liver; Male; Phosphatidylcholines; Phospholipids; Rats; Rats, Inbred Strains; Taurocholic Acid | 1989 |
Enhancement of Mdr2-mediated phosphatidylcholine translocation by the bile salt taurocholate. Implications for hepatic bile formation.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Bile; Biological Transport; Liver; Membrane Potentials; Membranes; Mice; Models, Biological; Octoxynol; Phosphatidylcholines; Proton-Translocating ATPases; Recombinant Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Solubility; Taurocholic Acid | 1995 |